Differential Gene Analysis of Langerhans Cell Histiocytosis and the Significance of MMP1-Targeted Drug Repositioning
Authors:
- 15 May 2024
- journal article
- research article
- Published by Springer Nature in Molecular Biotechnology
- Vol. 67 (5) , 2098-2110
Abstract
Langerhans cell histiocytosis (LCH) is a rare condition predominantly affecting young children. Activation of the MAPK pathway has offered key new insights into the pathogenesis of LCH; however, the precise mechanisms underlying its occurrence and development are still far from being completely elucidated. There is still a relapse/reactivation rate in patients with multisystem LCH. Therefore, this study aimed to investigate other potential LCH pathophysiologies and prospective therapeutic targets. The gene expression omnibus (GEO) database was used to retrieve gene expression profiles of LCH (GSE16395). Three distinct types of analyses were performed after identifying the common differentially expressed genes (DEGs) in LCH: hub gene identification, functional annotation, module construction, drug repositioning, and expression analysis via immunohistochemistry (IHC). We identified 417 common DEGs and 50 central hub genes. This functional study highlighted the significance of keratinization, skin development, and inflammation. In addition, we predicted new drug candidates (RS2 drugs targeting matrix metalloprotease1, MMP1) that could be used for LCH treatment. Finally, gene-miRNA and gene-TF networks and immune cell infiltration were analyzed for MMP1-related genes. MMP1 expression levels in LCH tissues were validated by IHC. Our study identified the central communal genes and novel drug candidates. These shared pathways and hub genes offer new perspectives on future mechanisms of action and therapeutic targets.Keywords
Funding Information
- National Regional Medical Center Opening Project (No. NRMC0103)
This publication has 40 references indexed in Scilit:
- Asiatic acid inhibits osteosarcoma cell migration and invasion via the AKT/Sp1/MMP1 axisEnvironmental Toxicology, 2024
- Guanxinning injection ameliorates cardiac remodeling in HF mouse and 3D heart spheroid models via p38/FOS/MMP1-mediated inhibition of myocardial hypertrophy and fibrosisBiomedicine & Pharmacotherapy, 2023
- MicroRNA Regulatory Network Analysis Using miRNet 2.02022
- Drug repositioning: Progress and challenges in drug discovery for various diseasesEuropean Journal of Medicinal Chemistry, 2022
- Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosisAmerican Journal of Hematology, 2021
- Investigation of the Skin Anti-photoaging Potential of Swertia chirayita Secoiridoids Through the AP-1/Matrix Metalloproteinase Pathway by Molecular ModelingInternational Journal of Peptide Research and Therapeutics, 2018
- Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistasPediatric Blood & Cancer, 2017
- Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 yearsPediatric Blood & Cancer, 2012
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009